DrugPatentWatch Database Preview
Ani Pharms Inc Company Profile
What is the competitive landscape for ANI PHARMS INC, and when can generic versions of ANI PHARMS INC drugs launch?
ANI PHARMS INC has two hundred and five approved drugs.
There is one US patent protecting ANI PHARMS INC drugs.
There are fourteen patent family members on ANI PHARMS INC drugs in eleven countries and forty-eight supplementary protection certificates in eleven countries.
Summary for Ani Pharms Inc
| International Patents: | 14 |
| US Patents: | 1 |
| Tradenames: | 116 |
| Ingredients: | 112 |
| NDAs: | 205 |
Drugs and US Patents for Ani Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms Inc | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 205153-003 | Oct 28, 2016 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Ani Pharms Inc | PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; propranolol hydrochloride | TABLET;ORAL | 072043-001 | Mar 14, 1988 | DISCN | No | No | See Pricing | See Pricing | |||||
| Ani Pharms Inc | GLIPIZIDE | glipizide | TABLET;ORAL | 074387-002 | Mar 4, 1996 | DISCN | No | No | See Pricing | See Pricing | |||||
| Ani Pharms Inc | VANCOCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 060180-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Pricing | See Pricing | |||||
| Ani Pharms Inc | DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 075432-003 | Oct 18, 2000 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Ani Pharms Inc | METHOXSALEN | methoxsalen | CAPSULE;ORAL | 087781-001 | Jun 8, 1982 | DISCN | No | No | See Pricing | See Pricing | |||||
| Ani Pharms Inc | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ani Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ani Pharms Inc | CASODEX | bicalutamide | TABLET;ORAL | 020498-001 | Oct 4, 1995 | 5,389,613 | See Pricing |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-004 | Jun 4, 1998 | 5,534,534*PED | See Pricing |
| Ani Pharms Inc | CASODEX | bicalutamide | TABLET;ORAL | 020498-001 | Oct 4, 1995 | 1,712,251 | See Pricing |
| Ani Pharms Inc | LITHOBID | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018027-001 | Approved Prior to Jan 1, 1982 | 4,264,573 | See Pricing |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-004 | Jun 4, 1998 | 7,538,133*PED | See Pricing |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-002 | Jun 4, 1998 | 5,703,110 | See Pricing |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-002 | Jun 4, 1998 | 5,508,297 | See Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ANI PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 4 mg, 8 mg, 16 mg and 32 mg | ➤ Subscribe | 2006-12-22 |
| ➤ Subscribe | Tablets | 32 mg/25 mg | ➤ Subscribe | 2009-03-06 |
| ➤ Subscribe | Tablets | 16 mg/12.5 mg and 32 mg/12.5 mg | ➤ Subscribe | 2008-06-25 |
International Patents for Ani Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2462637 | See Pricing |
| Norway | 20041740 | See Pricing |
| World Intellectual Property Organization (WIPO) | 03028708 | See Pricing |
| Japan | 2005508922 | See Pricing |
| Norway | 335070 | See Pricing |
| Mexico | PA04003234 | See Pricing |
| Japan | 4369752 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ani Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0328535 | 96C0021 | Belgium | See Pricing | PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209 |
| 0196132 | 94C0008 | Belgium | See Pricing | PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208 |
| 1129088 | 2014/008 | Ireland | See Pricing | PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919 |
| 0473687 | 3/1999 | Austria | See Pricing | PRODUCT NAME: FOSPHENYTOIN-NATRIUM; NAT. REGISTRATION NO/DATE: 1-22664 19980728; FIRST REGISTRATION: GB 00019/0157 19980204 |
| 0565634 | 06C0030 | France | See Pricing | PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607 |
| 0502314 | SPC/GB02/037 | United Kingdom | See Pricing | PRODUCT NAME: TELMISARTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/02/213/001 20020419; UK EU/1/02/213/002 20020419; UK EU/1/02/213/003 20020419; UK EU/1/02/214/004 20020419; UK EU/1/02/213/005 20020419; UK EU/1/02/213/006 20020419; UK EU/1/02/213/007 20020419; UK EU/1/02/213/008 20020419; UK EU/1/02/213/009 20020419; UK EU/1/02/213/010 20020419 |
| 0503785 | CA 2011 00026 | Denmark | See Pricing | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
